A new study from the Global WACh center finds that one in four children in low- and middle-income countries experiences severe Shigella-related diarrhea within early childhood.  Dr. Patricia Pavlinac, Associate Professor of Global Health, Director of Global Center for Integrated Health of Women, Adolescents, and Children, and Director of Enterics for Global Health Shigella Surveillance Network, Global Health is quoted.

It has been over a hundred years since the first tuberculosis vaccine was invented, and yet tuberculosis remains the world’s deadliest infectious disease.  That is now poised to change. There are several new TB vaccines now in phase III clinical trials and the world is closer than ever to a breakthrough that could save 8.5 million lives by 2050. Yet questions remain regarding how well the new vaccines will be accepted b

For people living with HIV (PLWH) in Africa, hypertension (HTN) is the leading cause of cardiovascular morbidity and mortality. However, despite increased access to effective antiretroviral therapy (ART), PLWH in Africa have limited access to high-quality care for cardiovascular diseases such as strokes, heart failure, and kidney diseases.  

Drs. Anjuli Wagner (Associate Professor, UW Global Health) and John Kinuthia (Affiliate Associate Professor, UW Global Health; Obstetrician Gynecologist, Kenyatta National Hospital) have received a National Institutes of Health award to fund their study, “Mechanisms of Action for mobile SMS PrEP adherence intervention (mWACH PrEP Mechanisms),” which aims to understand how digital health technologies work to support women to adhere to PrEP, a daily oral pill to prevent HIV.